The Pharmaceutical Accountability Foundation | Seeking fair pricing for medicines and medical technologies

AbbVie overcharged the Dutch health care system as much as €1.2 billion for Humira. Now we are taking them to court.

Press release More on the case

Healthcare is a human right. Abusive pricing should not limit access to it. We work to make sure it doesn't.

Who we are What we do Support us

Pharma companies have a duty of care to protect patients' right to health. We use the law to hold them accountable.

Legal guidelines for health Our latest case: Humira

“Six billion people have access to medicines today. So a lot has been achieved”

Rosalind Turkie - 26th March 2024

Wilbert Bannenberg, Chair of the Pharmaceutical Accountability Foundation, was interviewed by the Volkskrant on his life's work: promoting global equitable access to medicines. The article...

AbbVie tries to escape accountability for overcharging the Dutch healthcare system by 1.2 billion Euros

Rosalind Turkie - 15th November 2023

AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had abused...

The Pharmaceutical Accountability Foundation’s case against AbbVie: The Facts

Rosalind Turkie - 15th November 2023

Version 15 November 2023 About Adalimumab/Humira and pricing issues AbbVie’s blockbuster drug Adalimumab (brand name: Humira) for the treatment of rheumatoid arthritis is one of the best...

Answers to written Parliamentary questions by members Ellemeet and Westerveld (both Groenlinks) on the FtV lawsuit against AbbVie

Rosalind Turkie - 16th May 2023

Download the original (Dutch) here: antwoorden-op-kamervragen-over-de-rechtszaak-van-stichting-farma-ter-verantwoording-tegen-farmaceut-abbvieDownload Download the English translation here: Answers-to-written-Parliamentary-questions-on-FtV-case-against-AbbVieDownload

Accountability checklist

Rosalind Turkie - 17th April 2023

Infographic: 5 ways of legislating for access to medicines

Rosalind Turkie - 17th April 2023

All news

Resources

Cases and Case Studies

We investigate when companies may have charged excessive prices for medicines, and may bring cases if malfeasance is found.

LEARN MORE

Legal Guidelines for Public Health

Our most up-to-date information on how to use the law to ensure fair medicines prices.

LEARN MORE

Fair Pharma Scorecard

The Scorecard ranks pharmaceutical companies that made Covid-19 vaccines and therapuetics on how well their policies and practices reflect a commitment to human rights principles.

LEARN MORE

Recent News

“Six billion people have access to medicines today. So a lot has been achieved”

AbbVie tries to escape accountability for overcharging the Dutch healthcare system by 1.2 billion Euros

The Pharmaceutical Accountability Foundation’s case against AbbVie: The Facts

Answers to written Parliamentary questions by members Ellemeet and Westerveld (both Groenlinks) on the FtV lawsuit against AbbVie

Accountability checklist

Infographic: 5 ways of legislating for access to medicines

Resources

Cases and Case Studies

Legal Guidelines for Public Health

Fair Pharma Scorecard